The data from earlier studies suggested that prophylactic oophorectomy was associated with a significant 51% (95% CI 0.37–0.65) reduction in breast cancer risk for both BRCA1 and BRCA2 mutation carriers [57]. The gene discussed is BRCA2; the disease is breast carcinoma.